Research output per year
Research output per year
Personal profile
Research interests
I am an infectious disease mathematical modeller based in Population Health Sciences at the University of Bristol. I am currently working with Professors Peter Vickerman and Matthew Hickman on mathematical models of hepatitis C virus (HCV) and HIV prevention among high-risk populations including people who inject drugs. Specifically, my work focusses on modelling the impact and cost-effectiveness of scaling up prevention interventions and treatment to reduce prevalence and incidence of HCV and HIV.
I completed my PhD in 2015 at the University of Bath. My thesis used several mathematical modelling techniques to examine how the epidemiological dynamics of dengue are affected by interactions between serotypes and age-dependent variation in the extent to which people are exposed to mosquitoes.
Keywords
- Mathematical modelling of infectious diseases
- Hepatitis C virus
- HIV
- Cost-effectiveness analysis
- People who inject drugs
Fingerprint
Dive into the research topics where Hannah Fraser is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: A multi-stage analysis
Artenie, A., Trickey, A. J. W., Looker, K. J., Stone, J., Lim, A. G., Fraser, H., Degenhardt, L., Dore, G., Grebely, J., Cunningham, E. B., Hajarizadeh, B., Low-Beer, D., Luhmann, N., Webb, P., Hickman, M. & Vickerman, P. T., 1 Apr 2025, In: The Lancet Gastroenterology and Hepatology. 10, 4, p. 315-331 17 p.Research output: Contribution to journal › Article (Academic Journal) › peer-review
Open Access1 Citation (Scopus) -
Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling study
Ward, Z., Simmons, R., Fraser, H., Trickey, A., Kesten, J., Gibson, A., Reid, L., Cox, S., Gordon, F., Mc Pherson, S., Ryder, S., Vilar, J., Miners, A., Williams, J., Emmanouil, B., Desai, M., Coughlan, L., Harris, R., Foster, G. R. & Hickman, M. & 2 others, , 1 Feb 2025, In: The Lancet Regional Health - Europe. 49, 14 p., 101176.Research output: Contribution to journal › Article (Academic Journal) › peer-review
Open Access -
Modeling the impact of the COVID-19 pandemic on achieving HCV elimination amongst young and unstably housed people who inject drugs in San Francisco
Fraser, H., Stone, J., Facente, S. N., Artenie, A., Patel, S., Wilson, E., McFarland, W., Page, K., Vickerman, P. T. & Morris, M. D., 22 Jun 2024, (E-pub ahead of print) In: International Journal of Drug Policy. 131, 104452.Research output: Contribution to journal › Article (Academic Journal) › peer-review
Open Access